Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.

Looking ahead, Aurora expects its third-quarter 2026 consolidated revenue to increase year over year, led by 8% to 12% growth in global medical cannabis sales. Management also projects continued ...

Aurora Cannabis (ACB) is expected to post earnings of -$0.07 during its second quarter earnings on November 5, before the ...

Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - ...

As of July 2024, the CCB introduced a new license type for Propagation Cultivators. This license allows cultivators to focus on the early stages of cannabis plant growth, such as cloning and seed ...

Aurora Cannabis reported a second-quarter loss despite its medical cannabis and plant propagation segments driving revenue growth.

NEW YORK, NY, July 31, 2018 (GLOBE NEWSWIRE) -- In an effort to differentiate itself from the emerging cannabis market in Canada, PUF Ventures Inc. (OTCPK: PUFXF) (CSE: PUF) (Frankfurt: PU3) has taken ...

The cannabis industry is built on the backs of cannabis growers. When we worked on the environmental support specialist and propagation teams at Phat Panda’s Grow Op Farms in Spokane Valley, we ...

The bill, which would reform some cannabis regulations in Vermont, was passed by the Senate on Thursday. File photo by Glenn Russell/VTDigger The Senate on Thursday, by a unanimous voice vote, ...

The future of the REPROCANN program, which regulates the self-cultivation of medicinal cannabis in Argentina and authorizes personal cultivation, continues to be shrouded in uncertainty. Recent events ...

On June 10, 2024, H.612, An Act Relating to Miscellaneous Cannabis Amendments (the “Act”) became law, making a variety of changes to Vermont’s cannabis laws that will have significant implications for ...